FDA Clearance Beeken Biomedical has achieved FDA Class II clearance for the NuStat Hospital Product Line, including Trauma Pad XR and Flex XR, signaling a credible regulatory footprint and a proven path to hospital-based adoption.

Bleeding Control Focus Product portfolio centers on rapid hemostasis and wound care using Hemafiber Technology, presenting a clear value proposition for emergency responders and hospital wound care teams seeking faster, safer bleeding control solutions.

Mid-scale Growth With revenue in the estimated range of 1 to 10 million and a small-to-mid-size employee base, there is room to scale through hospital contracts, EMS partnerships, and targeted clinical endorsements.

Market Expansion Opportunity exists to expand into first responder agencies, rural clinics, and trauma centers that require ready-to-use hemostatic products, leveraging FDA clearance and existing NuStat product line.

Digital & Outreach Tech stack includes WordPress, Shopify, Mailchimp, and analytics tools, enabling scalable digital marketing, e-commerce enablement for direct sales, and optimized customer engagement to accelerate lead generation.